Lenalidomide Capsules

Lenalidomide Capsules

Categories : Oncology

Product Packaging : 30 in HDPE

Product Composition : 5mg, 10mg, 15mg, 20mg, 25mg

Lenalidomide Capsules are an immunomodulatory and anti-cancer medicine widely used in the treatment of multiple myeloma and certain hematological malignancies. It works by modulating the immune system, inhibiting tumor cell growth, and preventing angiogenesis, making it a key therapy in modern oncology.

Genliva Wellness LLP is a reliable Lenalidomide capsule exporter from India, offering high-quality oncology capsule formulations for export markets. As a pharma contract manufacturer and third party manufacturing company in India, Genliva supports international distributors, oncology hospitals, and pharmaceutical importers with consistent supply of high-value oncology medicines.

Send Message

Lenalidomide Capsules are an immunomodulatory and anti-cancer medicine widely used in the treatment of multiple myeloma and certain hematological malignancies. It works by modulating the immune system, inhibiting tumor cell growth, and preventing angiogenesis, making it a key therapy in modern oncology.

Genliva Wellness LLP is a reliable Lenalidomide capsule exporter from India, offering high-quality oncology capsule formulations for export markets. As a pharma contract manufacturer and third party manufacturing company in India, Genliva supports international distributors, oncology hospitals, and pharmaceutical importers with consistent supply of high-value oncology medicines.

  • Premium quality Lenalidomide capsules for multiple myeloma treatment
  • Trusted Genliva pharma exporter India for oncology capsule range
  • Manufactured by a GMP certified pharma manufacturer in India
  • Suitable for bulk export, private label, and third party pharma manufacturing
  • Widely used in hematology and oncology treatment protocols
  • Strong supply capability for export-focused pharmaceutical businesses

Lenalidomide Capsules are indicated for:

  • Multiple myeloma (MM)
  • Myelodysplastic syndromes (MDS) with deletion 5q abnormality
  • Mantle cell lymphoma (MCL)
  • Other hematological malignancies (as per clinical protocols)
  • Convenient oral capsule dosage for long-term oncology therapy
  • Enhances patient adherence in chronic cancer treatment
  • Suitable for large-scale capsule manufacturing and export supply
  • Ideal for high-value oncology product portfolios
  • Supports international distributors and tender-based procurement

whatsapp-app